Outcome of end-stage renal disease in patients with rare causes of renal failure. II. Renal or systemic neoplasms.
We describe a large experience with patients with end-stage renal disease (ESRD) whose primary cause was considered multiple myeloma, renal cell carcinoma and amyloidosis. Data were obtained by a collaboration of the majority of the ESRD Networks of the United States. The data presented reflect recent practice in the United States. Even though it is likely that some selection bias plays an important role, the demographic characteristics, choice of early treatment and overall survival data provide some assistance to physicians when advising their patients with these rare conditions. More detailed analyses are needed to assess the outcome by choice of treatment as well as the age- and treatment-adjusted survival for these diagnoses.
Port
F K
FK
Hemodialysis Unit, University of Michigan Medical School, Ann Arbor.
Nissenson
A R
AR
D000206:Actuarial Analysis; D000293:Adolescent; D000328:Adult; D000686:Amyloidosis / Q000150:complications / Q000453:epidemiology / Q000401:mortality; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000453:epidemiology / Q000401:mortality*; D005260:Female; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000628:therapy; D007680:Kidney Neoplasms / Q000150:complications / Q000453:epidemiology / Q000401:mortality*; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009101:Multiple Myeloma / Q000150:complications / Q000453:epidemiology / Q000401:mortality*; D015995:Prevalence; D006435:Renal Dialysis